Nikhil Kumaraswamy to lead padayatra against Bidadi township

Bengaluru, June 20 -- The opposition to the proposed Bidadi Township project is set to intensify with Janata Dal (Secular) Youth Wing State President Nikhil Kumaraswamy leading a massive padayatra on ... Read More

'May exam went well, was preparing for re-NEET': Ghaziabad student dies by suicide 2 days before June 21 exam

India, June 20 -- A 22-year-old NEET aspirant died by suicide at his residence in Ghaziabad on Friday, two days ahead of the NEET UG reexamination, scheduled for June 21. The victim, a resident of th... Read More

NYT Spelling Bee Guide: June 19, 2026 Hints, Strategy, and Solver Breakdown

New Delhi, June 20 -- The New York Times Spelling Bee continues to function as one of the most structurally elegant daily word puzzles in digital media. On June 19, 2026, players confronted a tightly ... Read More

Srinagar's Atiqa Mir becomes first Indian and Asian female racer selected for F1 Academy development programme

Srinagar, June 20 -- Eleven-year-old karting prodigy Atiqa Mir from Srinagar has achieved a historic milestone by becoming the first Indian and Asian female racer to be selected for the Formula 1 Acad... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More

• ««
• «
• 9391
• 9392
• 9393
• 9394
• 9395
• 9396
• 9397
• 9398
• 9399
• 9400
• »
• »»